When Your Body Keeps Sounding the Alarm: Understanding MCAS and How Myofascial Release Can Help

By Monika | Freedom Therapy MFR | Tucson, AZ | www.freedomtherapy.net

Do you feel like your body has become unpredictable — reactive, exhausting, and impossible to read? Skin flares after one meal, dizziness before another. A racing heart when nothing stressful happened. A gut that behaves for three weeks and then suddenly doesn't. A brain that goes foggy for no clear reason.

If you've seen multiple specialists, collected a stack of inconclusive test results, and still don't have a satisfying explanation — you may be dealing with something called Mast Cell Activation Syndrome, or MCAS.

This post goes deep. We'll cover what MCAS actually is, why it's so hard to diagnose, why it's becoming more common, how your nervous system and fascia are involved, and what myofascial release (MFR) therapy can offer as a supportive, body-centered complement to medical care.

What Is MCAS? Meet Your Body's Overzealous Security Guard

Think of your immune system as a building's security team. Most of the time, they respond to real threats — a fire, an intruder, a problem that needs attention. But sometimes, one particular guard — the mast cell — starts pulling the alarm for everything. A scent. A temperature change. A stressful thought. A piece of food that was perfectly fine last Tuesday.

Mast cells are specialized immune cells that live in virtually every tissue of your body — especially in your gut, skin, lungs, heart tissue, and connective tissue. Their job is to detect threats and release powerful chemical signals called mediators — including histamine, tryptase, prostaglandins, cytokines, and up to a thousand other compounds. In a healthy system, they release these chemicals in measured, appropriate amounts and stop when the threat passes.

In Mast Cell Activation Syndrome, the mast cells become hyper-reactive — releasing their chemical load too easily, too often, and sometimes for no identifiable reason. The result is a cascade of symptoms across multiple body systems that can feel wildly confusing, especially when you can't find a pattern or predict when the next wave is coming.

MCAS is not a simple allergy. Classic allergies have predictable IgE-mediated triggers (bee sting → hives, peanut → throat swelling). MCAS is different — it can fire without a consistent trigger, and the triggers that do exist are often invisible: stress, a shift in barometric pressure, a hormone change, a new fragrance.

There are three recognized types:

• Primary MCAS — tied to a genetic mutation (often the KIT gene D816V) that causes abnormal mast cell growth

• Secondary MCAS — driven by an underlying condition (infection, allergy, or autoimmune process) that continuously activates otherwise normal mast cells

• Idiopathic MCAS — the most common and most frustrating category: mast cells are misbehaving, but the underlying reason remains unclear

The Symptom Maze: Why MCAS Looks Different on Everyone

Here is what makes MCAS so notoriously difficult to recognize: it rarely looks the same twice — even in the same person.

Symptoms can include any combination of:

• Skin: flushing (sudden redness or warmth), hives, itching, swelling of the face, lips, eyes, or throat (angioedema)

• Gut: abdominal pain, bloating, diarrhea, constipation, nausea, vomiting, acid reflux

• Heart and circulation: rapid heart rate, low blood pressure, fainting or near-fainting, dizziness

• Lungs: shortness of breath, wheezing, chest tightness

• Nervous system: brain fog, difficulty concentrating, headaches, anxiety, sensory sensitivities, profound fatigue

• Musculoskeletal: bone pain, joint pain, generalized weakness

The key diagnostic hallmark isn't any specific symptom — it's the pattern: episodic, multi-system flares that don't fit neatly into one diagnosis and seem to shift week to week.

Some people experience dramatic flares — near-anaphylactic reactions. Others live in a constant low-grade simmer of fatigue, GI upset, and brain fog that never quite resolves. Both presentations can be MCAS.

You might want to investigate MCAS if you:

• Have seen multiple specialists without a clear unifying diagnosis

• Have a known diagnosis of POTS or Ehlers-Danlos Syndrome / hypermobility — research suggests 30–50% overlap between these conditions

• Are a Long COVID patient — studies show post-COVID mast cell activation symptoms are statistically nearly identical to MCAS in frequency and severity

• Have a history of chronic stress or trauma and notice your inflammatory or allergic reactions have worsened over time

• React unpredictably to many foods, fragrances, medications, or environmental exposures

What's Driving the Rise in MCAS? Why So Many People Are Struggling Now

If you're reading this thinking, this sounds like half the people I know — you're not imagining it. MCAS diagnoses have been rising, and there are real biological reasons why.

Key contributors include:

• Genetic predisposition — some people are simply born with more reactive mast cells

• Chronic infections — especially COVID-19. Research has found that post-COVID mast cell activation symptoms matched MCAS patients pre-treatment in both symptom count and severity

• Environmental toxin load — pesticides, herbicides, heavy metals, BPA from plastics, mycotoxins from mold, and air pollution all directly stimulate mast cell activity

• Gut microbiome disruption — the gut is one of the densest sites of mast cell activity; chronic bacterial imbalances create fertile conditions for mast cell overactivation

• Chronic stress and nervous system dysregulation — when the body lives in fight-or-flight, it releases a hormone called CRH (corticotropin-releasing hormone) that directly triggers mast cells to degranulate

• Hypermobile connective tissue — people with joint hypermobility and Ehlers-Danlos Syndrome appear to have structurally different connective tissue environments that make mast cells more reactive

A Houston Methodist study examining young adult women with complex gastrointestinal symptoms found striking overlap in diagnoses of hypermobility, POTS, and MCAS. Another study of 100 young POTS patients found that when broader criteria were applied, 34 of 100 met criteria for all three conditions simultaneously.

This isn't coincidence — it's a pattern pointing to a shared root: dysregulation of connective tissue, the nervous system, and the immune system as an interconnected whole.

Why Is MCAS So Hard to Diagnose and Treat?

Many people with MCAS spend years being dismissed, misdiagnosed, or simply unheard. The barriers are real — and worth understanding.

Structural diagnostic challenges:

• Official criteria require elevated mast cell mediators measured during an acute episode — specifically serum tryptase within 1–4 hours of symptom onset. This means heading to a lab while actively flaring, which almost no one does.

• Most general practitioners and many specialists lack training in MCAS. Proper evaluation typically requires an allergist or immunologist with specific expertise.

• Because symptoms cross so many body systems, patients often spend years being referred between GI specialists, cardiologists, neurologists, and dermatologists — each treating one piece without seeing the whole picture.

• The "IgE empire" in conventional allergy training overshadows the non-IgE immune pathways that MCAS actually involves.

• The fluctuating, invisible nature of MCAS symptoms is poorly understood by insurance assessors, disability systems, and even well-meaning family members.

Diagnostic tools that do exist:

• Serum tryptase at baseline vs. during an acute episode (the key comparison)

• Urine metabolites: histamine, prostaglandins, and leukotrienes measured during or just after a flare

• Response to H1 and H2 antihistamines and mast cell stabilizers — therapeutic response is itself part of the diagnostic picture

• Bone marrow biopsy when primary or clonal MCAS is suspected

• A detailed symptom diary tracking episodes across organ systems — often the most powerful evidence a patient can bring to a specialist

The most honest statement medicine can offer right now: MCAS is real, it is underdiagnosed, and the path to diagnosis requires persistence, the right specialist, and often a functional or integrative medicine perspective alongside conventional testing.

The Nervous System: The Missing Link in MCAS

Here is the connection that conventional medicine is only beginning to fully appreciate — and that body-centered therapies like MFR are particularly well-suited to address.

Mast cells are not scattered randomly in your tissues. They are strategically positioned right next to nerve fibers and blood vessels — stationed at every communication junction in the body. They have receptors for stress hormones, neuropeptides, and neural signals. They are constantly listening to your nervous system.

The vagus nerve — your body's great parasympathetic highway — plays a central regulatory role. Running from your brainstem down through your neck, heart, lungs, and into your gut, the vagus nerve acts like the "brake pedal" of your nervous system: it calms the fight-or-flight response and modulates inflammation throughout the body.

When vagus nerve function is compromised — through chronic stress, trauma, or accumulated fascial tension — histamine production increases and inflammatory mediators rise. When the brake fails, the immune alarm keeps sounding.

Research has confirmed that vagus nerve stimulation can inhibit cardiac mast cell activation — a clear, bidirectional pathway between nervous system tone and immune behavior. The cholinergic anti-inflammatory reflex, activated by the vagus nerve, directly suppresses pro-inflammatory cytokines like TNF-α and IL-1β.

The stress hormone CRH acts directly on mast cell receptors, triggering degranulation. This is why MCAS flares so often worsen during stressful periods — even without any external allergen. For people with MCAS, stress is not just emotionally difficult. It is biologically destabilizing.

The Fascia Connection: What Most Doctors Haven't Told You

This is the piece I find most important — and the one most people with MCAS have never heard from their medical providers.

Fascia — your body's continuous inner web of connective tissue — is not a passive bystander in MCAS. It may be one of the primary environments where the condition plays out.

In a landmark 2023 study published through the NIH, researchers made the first-ever documented discovery of mast cells living inside human superficial fascia. The findings were striking:

• 51% of the mast cells were nestled between collagen fibers

• 25% were positioned directly adjacent to nerve fibers

• 24% were located next to blood vessels

The researchers even photographed mast cells in direct contact with fascial fibroblasts — the cells responsible for maintaining fascial structure — and confirmed paracrine (cell-to-cell) communication between them.

In plain language: mast cells live in your fascia, communicate with your fascial cells, and respond directly to what happens in that tissue.

Research published in Frontiers in Neurology (2024) extended this further: when mast cells release mediators at neuromuscular-myofascial junctions — the intersections of nerves and fascial tissue — it can trigger an escalating, multi-system inflammatory cascade. Chronic fascial restriction doesn't just cause pain and stiffness; it actively provokes local immune-inflammatory responses.

Think of it this way: chronic fascial restriction is like a persistent kink in a garden hose. Pressure builds at the kink point. The mast cells in and around that restriction feel the mechanical stress, become irritated, and release their chemical signals. Those signals inflame the surrounding tissue, tighten the fascia further, and recruit more immune activity — a self-reinforcing loop.

This mechanism is especially significant for people with hypermobile connective tissue, where the fascial architecture is already under different structural demands, and where mast cell involvement in chronic pain-inflammation-stress cascades is a well-documented clinical pattern.

How Myofascial Release (MFR) Can Support MCAS

Let me be clear: MFR does not treat or cure MCAS. Medical care, antihistamines, mast cell stabilizers, and physician guidance remain essential. MFR is a complement — never a replacement — for that care.

What MFR can do is address several of the biological environments that make MCAS worse, and that medications alone cannot fully reach.

How MFR supports the MCAS patient:

• Calming the mast cells' neighborhood — by releasing fascial restriction in the tissue where mast cells live, MFR reduces the mechanical irritation that drives local activation

• Reducing pro-inflammatory cytokines — research shows MFR lowers circulating IL-6 and TNF-alpha, the very cytokines central to the MCAS inflammatory cascade

• Boosting vagal tone — MFR stimulates the parasympathetic nervous system, improving vagus nerve function and increasing acetylcholine — the neurotransmitter that signals the immune system to stand down

• Downregulating sympathetic dominance — in MCAS, the "gas pedal" of the nervous system is chronically engaged. MFR is one of the few manual therapies shown to downregulate autonomic nervous system arousal at a tissue level

• Activating endocannabinoid receptors in fascia — research suggests MFR stimulates fascial endocannabinoid receptors, reducing both pain and anxiety through pathways that complement conventional treatment

• Creating physiological safety — the sustained, gentle pressure of MFR communicates to the nervous system that the body is not in danger, one of the most powerful inputs for a system that has been on high alert

An important clinical note: for people with MCAS, MFR sessions must be especially gentle and carefully paced. Overworking the tissue can itself become a mast cell trigger. The goal is slow, steady, cumulative calming — not deep work that pushes the system past its threshold. Sessions are typically shorter, with more recovery time between them, particularly during active flare periods.

A Gentle At-Home MFR Practice for Nervous System Support

This practice is designed to calm the nervous system, reduce fascial tension around the diaphragm and vagus nerve pathway, and create a felt sense of safety in the body. It is gentle and appropriate for most people with MCAS or MCAS-like symptoms.

Stop if any step triggers symptoms. This is not a substitute for medical care.

What you need: A quiet space to lie down, a small folded towel or thin pillow, 15–20 minutes.

Step 1 — Diaphragm Release (5 minutes)Lie on your back, knees bent, feet flat. Place both hands on your belly just below your ribcage, fingertips lightly touching at the midline. Breathe in slowly through your nose and notice your hands rise. On the exhale, allow your hands to gently sink — following, not pressing. Stay here for five slow breaths, feeling for subtle warmth or a gentle release under your palms. That is your fascia beginning to respond.

Step 2 — Sternal and Chest Softening (5 minutes)Place one hand flat on the center of your chest. Place the other hand over the first. Imagine warmth radiating from your palms into the tissue beneath. With each exhale, whisper internally: let. You are not forcing anything open — simply removing the instruction to hold. The vagus nerve travels right through this region; sustained gentle contact nourishes the parasympathetic pathway.

Step 3 — Neck and Jaw Release (3–4 minutes)Place both hands very lightly behind your neck, cradling the base of your skull. Let your elbows rest on the floor so your arms are fully relaxed. Allow your jaw to part slightly — just enough that your teeth are not touching. With each exhale, soften the jaw, temples, and base of the skull a little more. The vagus nerve exits the skull in this region; tension here can dampen vagal tone.

Step 4 — Long Rest (3–5 minutes)Lay your hands at your sides, palms facing up. Let your feet fall naturally outward. Take three deeper breaths, then return to normal breathing. Simply notice — not fixing, not analyzing. Notice where your body feels softer than it did 15 minutes ago.

Safety notes: During an active MCAS flare, reduce each step to 2 minutes and focus only on breath. Do not use this practice during anaphylaxis or acute systemic reactions. If pregnant, prop yourself at a slight incline. If you have had recent abdominal or chest surgery, obtain physician clearance before beginning Steps 1 or 2.

10 Questions & Answers About MCAS and MFR

Q1: Is MCAS the same as a severe allergy or anaphylaxis?

Not exactly. Classic allergies are triggered by a specific IgE-mediated immune response to a known substance — like peanuts or bee venom — and are typically consistent and predictable. MCAS involves mast cells firing excessively across multiple triggers and pathways, many of which are non-IgE, meaning standard allergy testing often comes back normal even in people with significant MCAS symptoms. Some people with MCAS do experience anaphylaxis-like episodes, but the condition is broader and more complex than a single allergen sensitivity.

Q2: Can I have MCAS even if my allergy tests are negative?

Yes — and this is one of the most common sources of confusion and dismissal. Standard IgE allergy panels test only one pathway of immune reactivity. MCAS frequently operates through non-IgE pathways, meaning a clean allergy panel does not rule out MCAS. If your symptoms involve multiple body systems, come and go unpredictably, and respond to antihistamines, that clinical picture warrants further investigation even with negative allergy tests.

Q3: How is MCAS officially diagnosed?

The diagnosis requires three criteria: (1) episodic symptoms consistent with mast cell mediator release affecting two or more organ systems; (2) elevated mast cell mediators — most commonly serum tryptase at 20% above baseline plus 2 ng/mL, measured during an acute episode; and (3) a positive response to mast cell-targeted treatments such as antihistamines or mast cell stabilizers. Because tryptase must be drawn within 1–4 hours of a flare, diagnosis is logistically challenging. A detailed symptom diary is often the most accessible starting point.

Q4: Why do so many people with POTS or EDS also have MCAS?

POTS, Ehlers-Danlos Syndrome, hypermobility spectrum disorders, and MCAS share a common thread: dysregulation of connective tissue, the autonomic nervous system, and immune signaling. In hypermobile individuals, the structural integrity of connective tissue is different, and mast cells — which live within that tissue — appear to be more reactive as a result. Research has found that 30–50% of people with POTS or EDS have clinically significant MCAS symptoms, and studies have documented all three conditions occurring together in a substantial percentage of complex patients.

Q5: Is MCAS a real diagnosis, or is it overdiagnosed?

MCAS is a legitimate, recognized medical diagnosis supported by peer-reviewed research and formal diagnostic criteria. The more accurate picture is that it is historically underdiagnosed rather than overdiagnosed — particularly because it requires specialist expertise, specific lab timing, and awareness of non-IgE immune pathways that many clinicians were not trained to consider. With growing awareness through Long COVID research and the EDS/POTS community, more patients are finally getting answers they have waited years for.

Q6: Can Long COVID cause MCAS or MCAS-like symptoms?

Research strongly suggests yes. Studies have found that post-COVID patients report mast cell activation symptoms at rates nearly identical to diagnosed MCAS patients before treatment — in both the number and severity of symptoms. The current hypothesis is that COVID-19 infection can trigger persistent mast cell dysregulation, either by directly activating mast cells or by driving a chronic low-grade inflammatory state that keeps them sensitized. This is one of the key reasons MCAS awareness has expanded so rapidly since 2020.

Q7: What does the vagus nerve have to do with MCAS?

The vagus nerve is your body's primary parasympathetic regulator — the "brake pedal" that calms the fight-or-flight response and modulates immune activity throughout the body. Mast cells have receptors for neural signals and are positioned right next to nerve fibers throughout your tissues. When vagal tone is low — due to chronic stress, trauma, or accumulated fascial tension — mast cells lose a key inhibitory signal and become more reactive. Research has confirmed that vagus nerve stimulation can inhibit mast cell activation, making vagal tone a meaningful therapeutic target in MCAS management.

Q8: What is fascia, and why does it matter in MCAS?

Fascia is the continuous web of connective tissue that surrounds and connects every muscle, organ, nerve, and blood vessel in your body. A landmark 2023 NIH study confirmed for the first time that mast cells are present within human superficial fascia — distributed between collagen fibers, near nerve fibers, and adjacent to blood vessels. The researchers documented direct contact between mast cells and fascial fibroblasts. This means chronic fascial restriction is not just a musculoskeletal problem — it creates a local environment of mechanical stress that can directly activate the mast cells living within that tissue.

Q9: Is MFR safe for people with MCAS?

For most people with MCAS, gentle MFR is well-tolerated and can be a valuable supportive therapy — but it requires a therapist who understands the condition and adjusts their approach accordingly. Sessions should be gentler and shorter than standard MFR, especially during or near flare periods. Deep or aggressive tissue work can itself become a mast cell trigger. The goal is cumulative nervous system calming rather than intensive structural release. Always inform your MFR therapist about your MCAS diagnosis and coordinate MFR as part of your broader care plan alongside your physician.

Q10: Where do I start if I suspect I have MCAS?

Start by keeping a detailed symptom diary — tracking each episode across all affected body systems, potential triggers, timing, and duration. This is the most useful document you can bring to a specialist. Request a referral to an allergist or immunologist with MCAS experience, or seek out a functional or integrative medicine practitioner familiar with the condition. If you have POTS or hypermobility, a provider experienced in the POTS/EDS/MCAS overlap will be especially valuable. Know that the path to diagnosis can be long — persistent self-advocacy matters. And consider adding body-centered support like MFR to help regulate your nervous system and reduce the biological load on your mast cells while you navigate the diagnostic process.

MFR is a complement to — never a replacement for — your physician's care. Please continue all prescribed medications and always consult your doctor before beginning any new self-care practice if you have a diagnosed condition.

Written by Monika | Freedom Therapy MFR | Tucson, AZ*www.freedomtherapy.net*

Interested in exploring MFR as a supportive part of your care? Reach out through the website to start a conversation.